Aerovate Therapeutics Stock Target Price and Analyst Consensus
| AVTE Stock | USD 2.68 0.02 0.75% |
The current analyst and expert consensus on Aerovate Therapeutics is Hold with 4 hold recommendations. The current projected Aerovate Therapeutics target price consensus is 32.00 with 4 analyst opinions. One of the most common ways Aerovate Therapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Aerovate Therapeutics vendors, executives, and/or customers. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Aerovate Therapeutics. We encourage you to use your own analysis of Aerovate Therapeutics to validate this buy or sell advice. Aerovate Therapeutics recommendation module provides expert sentiment on the projected Aerovate Therapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 3.6458.
Lowest Forecast 29.12 | Highest Forecast 35.52 | Target Price 32 |
Aerovate |
It's important to approach Aerovate Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Aerovate Therapeutics price targets
Aerovate Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Aerovate Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Aerovate Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Aerovate Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Aerovate Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Aerovate Therapeutics is a key component of Aerovate Therapeutics valuation and have some predictive power on the future returns of a Aerovate Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aerovate Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Momentum Invested over 40 shares | |
 | Disruptive Technologies Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Manufacturing Invested over 30 shares | |
 | ESG Investing Invested few shares |
Check out Macroaxis Advice on Aerovate Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Please note, the presentation of Aerovate Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aerovate Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aerovate Therapeutics' management manipulating its earnings.